Mucinous cystadenocarcinoma of the ovary usually responds to chemotherapy. Chemotherapy is one of the important means of treating this disease and can be used in combination with surgery or as a palliative treatment method.
Ovarian mucinous cystadenocarcinoma has a certain sensitivity to chemotherapy drugs, and commonly used regimens include paclitaxel combined with carboplatin. Chemotherapy drugs can reach the whole body through the blood system and control tiny lesions or potential metastases that are difficult to remove with surgery. Before chemotherapy, the patient's liver and kidney function, bone marrow reserve and overall tolerance need to be assessed. Usually every 3-4 weeks is a cycle. The specific number of treatment courses is determined based on the tumor stage and treatment response. Adverse reactions such as nausea, vomiting, and bone marrow suppression may occur during treatment, and symptoms can be relieved by auxiliary medication.
For patients with advanced inoperable or recurrent disease, chemotherapy is the main means to control the progression of the disease. Targeted therapy drugs such as bevacizumab may enhance the effect of traditional chemotherapy, but attention should be paid to complications such as hypertension and proteinuria. Platinum-resistant patients have limited second-line chemotherapy options, and alternative drugs such as topotecan and liposomal doxorubicin may be considered. Regular imaging examinations and tumor marker monitoring are essential to evaluate the effectiveness of chemotherapy.
During chemotherapy, you should ensure adequate nutritional intake, eat more high-protein foods such as fish, meat, eggs, and milk, and supplement with appropriate amounts of vitamin-rich fruits and vegetables. Keep your mouth clean to prevent mucositis, exercise moderately to maintain muscle mass, and review routine blood tests regularly to monitor bone marrow function. After treatment, long-term follow-up is still required, pay attention to signs of recurrence such as abdominal pain and distension, and promptly report changes in physical condition to the attending doctor.

Becker 